Aprea Therapeutics, Inc. Preferred Stock Convertible Shares Issuable
Aprea Therapeutics, Inc. (APRE) had Preferred Stock Convertible Shares Issuable of 28.11 thousand shares as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:PreferredStockConvertibleSharesIssuable · last filed 2025-05-14
- 2025-03-31: Preferred Stock Convertible Shares Issuable 28.11K shares.
- 2024-12-31: Preferred Stock Convertible Shares Issuable 28.11K shares.
- 2024-09-30: Preferred Stock Convertible Shares Issuable 28.11K shares.
- 2024-06-30: Preferred Stock Convertible Shares Issuable 28.11K shares.
| Period end | Preferred Stock Convertible Shares Issuable |
|---|---|
| 2025-03-31 | 28.11K shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 28.11K shares 10-Q · filed 2025-05-14 |
| 2024-09-30 | 28.11K shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 28.11K shares 10-Q · filed 2024-08-12 |
| 2024-03-31 | 28.11K shares 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |